There is 1 paper on PLSCR3 in aging research: none in people yet, 1 in animals.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: American Heart Association and 2 more
- Animals1
Effects
3Kidney function
no changein mice1
1 study
Kidney function
no changein mice1
PLSCR3 showed no clear effect on kidney function in mice (tubular epithelial-specific knockout under normal conditions).
Animalstubular epithelial-specific knockout under normal conditionskidney
Protection against acute kidney injury
is required forin mice1
1 study
Protection against acute kidney injury
is required forin mice1
PLSCR3 is required for protection against acute kidney injury in mice (tubular epithelial-specific knockout during cisplatin- or rhabdomyolysis-induced AKI).
Animalstubular epithelial-specific knockout during cisplatin- or rhabdomyolysis-induced AKIkidney
Protection against cisplatin-associated cell death
is required forin human cells1
1 study
Protection against cisplatin-associated cell death
is required forin human cells1
PLSCR3 is required for protection against cisplatin-associated cell death in human cells.
Cellsknockout cell lines and siRNA knockdown in HK-2 and primary murine tubular epithelial cells